Representative before the EPO

Employment test 11 - 50 employees
Company dna bohest ag
operating since 1888
825.89
Headquarter in Basel and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Florian Bielefeldt has worked on the following 6 EPO patent applications which have been published in the last five years:

EP12725349

COMPOSITIONS FOR PERCUTANEOUS ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE AGENTS

IPC classification:
A61K 9/00, A61K 9/70, A61K 47/32
Applicant:
Novartis AG
Agent:
Clive Beresford Thompson, GlaxoSmithKline
Agent:
Florian Bielefeldt, Novartis Consumer Health SA
Status:
GRANT OF PATENT INTENDED
EP15161511

RAPID STERILITY MICROASSAY

IPC classification:
C12Q 1/04, C12Q 1/22
Applicant:
Novartis AG
Agent:
Carpmaels & Ransford LLP
Agent:
Florian Bielefeldt, Novartis AG
Status:
EXAMINATION IN PROGRESS
EP15194859

GENERIC ASSAYS FOR DETECTION OF MAMMALIAN REOVIRUS

IPC classification:
C12Q 1/70
Applicant:
Novartis AG
Agent:
Florian Bielefeldt, Novartis AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14781529

TREATED FILTER

IPC classification:
C12N 7/02
Applicant:
Novartis AG
Agent:
Carpmaels & Ransford LLP
Agent:
Florian Bielefeldt, Novartis AG
Status:
GRANT OF PATENT INTENDED
EP14798760

REMOVAL OF RESIDUAL CELL CULTURE IMPURITIES

IPC classification:
A61K 39/00, C07K 1/18
Applicant:
Novartis AG
Agent:
Florian Bielefeldt, Novartis AG
Agent:
Nicholas James Finnie, Novartis International AG
Status:
EXAMINATION REQUESTED
EP15791795

INSECTICIDAL COMPOSITION AND METHOD

IPC classification:
A01N 25/28, A01N 25/34, A01N 47/24, A01N 53/00, A01N 57/12, A01N 57/14, A01N 57/16
Agent:
Florian Bielefeldt, Lonza AG
Status:
Request for examination was made

Please Sign in to use this feature